@FiercePharma: Roche's O'Day says portfolio firing well in international markets, Japan a star. FiercePharmaAsia story | Follow @FiercePharma
@CarlyHFierce: "I've heard two CEOs use the word 'bold' in the last couple months..." - DB's Gilbert insinuating a $PFE $AGN tie-up. | Follow @CarlyHFierce
> Doctors Without Borders/Médecins Sans Frontières is calling on the South African government to override AbbVie's ($ABBV) patent on an HIV drug, Aluvia, that has been in short supply for 6 months. Release
> GlaxoSmithKline ($GSK) said its shingles vaccine, Shingrix, demonstrated 90% efficacy in adults 70 years and over, compared with placebo. Release
> GSK said a long-term safety study of its combination lung drug Advair showed that it had a safety profile comparable with fluticasone propionate--one of its two active ingredients--in adolescents and adults with asthma. Release
> Mylan ($MYL) rolled out its generic version of Spectrum Pharmaceuticals' ($SPPI injectable therapy Fusilev (levoleucovorin calcium), which had U.S. sales of about $200 million over the 12 months ended June 30. Release
Medical Device News
@FierceMedDev: ICYMI: Healthcare, wellness drive Philips growth as it works to shed lighting. Report | Follow @FierceMedDev
@VarunSaxena2: ICYMI: J&J device heads say the new med tech innovation model calls for more external partnerships. Article | Follow @VarunSaxena2
@EmilyWFierce: Stanford scientists reveal artificial skin device for prosthetics. Story | Follow @EmilyWFierce
> Endologix off more than 25% on planned $211M merger with TriVascular. More
> NEA, Cleveland Clinic, Greatbatch back $20M Series A for neuromodulation heart failure startup. Story
Biotech News
@FierceBiotech: GlaxoSmithKline's cardio R&D group records another big PhIII flop. News | Follow @FierceBiotech
@JohnCFierce: Kite Pharma taps Mitch Gold's upstart Alpine for T-cell immuno-tech. Article | Follow @JohnCFierce
> After a big-money Allergan deal, Taris returns with a $32M round and a new pipeline. Item
> After Eli Lilly flop, Merck adds a futility challenge to huge PhIII anacetrapib study. Article
Pharma Manufacturing News
> U.K. cites the GSK China plant that was damaged by explosions. News
> Sun recalls 1M-plus boxes of generic Claritin made at Ohm Labs. Report
> Boehringer's Roxane plant mixes up APIs for blood pressure med. Story
> Lawsuit challenges Cipla's buyout of InvaGen. Item
> Spain's Grifols opening $100M warehouse, labeling operation in Dublin. Article
Drug Delivery News
> MIT: Ultrasound gives GI drugs a quicker delivery with less discomfort. Story
> 'Screen door' through blood-brain barrier gives Parkinson's drugs a way in. More
> Capsugel launches coating-free enteric protection delivery platform for oral meds. News
> FDA approval of Endo and BDSI's painkiller a win for buccal drug delivery. Item
> Flowonix to develop drug delivery implant for Cerebral's neurological candidates. Report
Pharma Asia News
> Tata Institute says paper shows 'early success' in malaria vaccine. More
> Indian health officials slam Lancet editor's comments. Article
> Lilly takes Q3 hits in emerging markets on FX, but Japan shows bright spots. Story
> Roche's O'Day says portfolio firing well in international markets, Japan a star. More
> China's ZAI Lab goes novel in drug development, makes key hire. Report
And Finally... Investment banks may be worried now that Valeant Pharmaceuticals ($VRX) says it will be more selective about M&A; the specialty drugmaker has accounted for a big chunk of investment-banker fees over the past three years. Report